Orthopediatrics (KIDS) Total Non-Current Liabilities (2018 - 2026)
Orthopediatrics' (KIDS) quarterly Total Non-Current Liabilities came in at $116.3 million in Q1 2026, up 35.86% year-on-year from $85.6 million in Q1 2025, and little changed on a QoQ basis from $115.8 million in Q4 2025.
Orthopediatrics (KIDS) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
Orthopediatrics (KIDS) has 9 years of Total Non-Current Liabilities data on file, last reported at $116.3 million in Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities rose 35.86% year-over-year to $116.3 million in Q1 2026; TTM through Mar 2026 was $116.3 million, a 35.86% increase from a year earlier, with the FY2025 full-year figure at $115.8 million, up 36.79% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $116.3 million, roughly flat from $115.8 million in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for KIDS reached as high as $116.3 million in Q1 2026 and fell as low as $10.2 million in Q3 2023.
- Historically, Total Non-Current Liabilities has averaged $56.8 million across 5 years, with a median of $51.6 million in 2022.
- Across the five-year window, Total Non-Current Liabilities plunged 85.87% in 2023 and soared 722.05% in 2024, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $18.2 million in 2022, then increased by 10.14% to $20.1 million in 2023, then jumped by 322.26% to $84.7 million in 2024, then jumped by 36.79% to $115.8 million in 2025, then grew by 0.4% to $116.3 million in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $116.3 million in Q1 2026, $115.8 million in Q4 2025, and $110.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 173.90 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.53 Bn | 125.65 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 107.77 Bn | 98.55 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 67.72 Bn | 66.27 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 48.21 Bn | 44.54 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 3.53 Bn |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.05 Bn | 1.98 Bn | 24.21 Bn |
| 8 | Smith & Nephew | 26.76 Bn | 26.18 Bn | - | 3.57 Bn |
| 9 | Koninklijke Philips | 25.27 Bn | 22.15 Bn | 2.07 Bn | 9.85 Bn |
| 10 | Orthopediatrics | 466.60 Mn | 452.35 Mn | 43.39 Mn | 116.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 116.30 Mn |
| Dec 31, 2025 | 115.84 Mn |
| Sep 30, 2025 | 110.95 Mn |
| Jun 30, 2025 | 109.43 Mn |
| Mar 31, 2025 | 85.60 Mn |
| Dec 31, 2024 | 84.68 Mn |
| Sep 30, 2024 | 83.75 Mn |
| Jun 30, 2024 | 19.90 Mn |
| Mar 31, 2024 | 20.78 Mn |
| Dec 31, 2023 | 20.05 Mn |
| Sep 30, 2023 | 10.19 Mn |
| Jun 30, 2023 | 10.25 Mn |
| Mar 31, 2023 | 17.92 Mn |
| Dec 31, 2022 | 18.21 Mn |
| Sep 30, 2022 | 17.98 Mn |
| Jun 30, 2022 | 72.51 Mn |
| Mar 31, 2022 | 51.62 Mn |
| Dec 31, 2021 | 49.19 Mn |
| Sep 30, 2021 | 54.46 Mn |
| Jun 30, 2021 | 55.73 Mn |